Roxadustat Versus Erythropoietin: The Comparison of Efficacy in Reversing Ventricular Remodeling in Dialysis Patients with Anaemia

Conclusions: The increase of haemoglobin was associated with improving left ventricular hypertrophy in dialysis patients. However, the beneficial effects between roxadustat and recombinant human erythropoietin on left ventricular mass index did not show clear superiority or inferiority in six months.PMID:38464833 | PMC:PMC10920838 | DOI:10.7150/ijms.87870

Source: International Journal of Medical Sciences - March 11, 2024 Category: Biomedical Science Authors: Meng Ying Wang Xiao Qi Liu Ting Ting Jiang Wen Tao Liu Yang Huang Yu Lin Huang Feng Yong Jin Qing Zhao Qin Yi Wu Gui Hua Wang Xiong Zhong Ruan Kun Ling Ma Source Type: research